UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

The lancet oncology, 2015-07, Vol.16 (7), p.839-847

2015

Volltextzugriff (PDF)

Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation

Aging cell, 2013-06, Vol.12 (3), p.489-498

2013

Volltextzugriff (PDF)

Metformin reduces endogenous reactive oxygen species and associated DNA damage

Cancer prevention research (Philadelphia, Pa.), 2012-04, Vol.5 (4), p.536-543

2012

Volltextzugriff (PDF)

The Use of Aspirin and the Risk of Mortality in Patients with Prostate Cancer

The Journal of urology, 2015-04, Vol.193 (4), p.1220-1225

2015

Volltextzugriff (PDF)

Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer

European journal of cancer (1990), 2014-11, Vol.50 (16), p.2838-2845

2014

Volltextzugriff (PDF)

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

Endocrine-related cancer, 2010-06, Vol.17 (2), p.351-360

2010

Volltextzugriff (PDF)

Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms

Diabetes (New York, N.Y.), 2015-05, Vol.64 (5), p.1632-1642

2015

Volltextzugriff (PDF)

The Use of Metformin and Colorectal Cancer Incidence in Patients with Type II Diabetes Mellitus

Cancer epidemiology, biomarkers & prevention, 2013-10, Vol.22 (10), p.1877-1883

2013

Volltextzugriff (PDF)

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (14), p.4429-4438

2013

Volltextzugriff (PDF)

Prediagnostic plasma IGFBP‐1, IGF‐1 and risk of prostate cancer

International journal of cancer, 2015-05, Vol.136 (10), p.2418-2426

2015

Volltextzugriff (PDF)

Type 2 diabetes and the risk of mortality among patients with prostate cancer

Cancer causes & control, 2014-03, Vol.25 (3), p.329-338

2014

Volltextzugriff (PDF)

eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (32), p.14134-14139

2010

Volltextzugriff (PDF)

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

Cancer prevention research (Philadelphia, Pa.), 2008-10, Vol.1 (5), p.369-375

2008

Volltextzugriff (PDF)

The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes

Diabetes care, 2013-01, Vol.36 (1), p.124-129

2013

Volltextzugriff (PDF)

The use of metformin in patients with prostate cancer and the risk of death

Cancer epidemiology, biomarkers & prevention, 2014-10, Vol.23 (10), p.2111-2118

2014

Volltextzugriff (PDF)

Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer

Cell reports (Cambridge), 2018-07, Vol.24 (1), p.47-55

2018

Volltextzugriff (PDF)

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

The lancet oncology, 2008-11, Vol.9 (11), p.1039-1047

2008

Volltextzugriff (PDF)

Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (24), p.7160-7167

2016

Volltextzugriff (PDF)

A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts

JNCI : Journal of the National Cancer Institute, 2013-01, Vol.105 (2), p.95-103

2013

Volltextzugriff (PDF)

Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin

Molecular cancer therapeutics, 2014-02, Vol.13 (2), p.399-409

2014

Volltextzugriff (PDF)

Hyperglycemia, Insulin Resistance, Impaired Pancreatic β-Cell Function, and Risk of Pancreatic Cancer

JNCI : Journal of the National Cancer Institute, 2013-07, Vol.105 (14), p.1027-1035

2013

Volltextzugriff (PDF)

Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer

European urology, 2016-11, Vol.70 (5), p.808-815

2016

Volltextzugriff (PDF)

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

BMJ (Online), 2012-05, Vol.344 (may30 3), p.e3645-e3645

2012

Volltextzugriff (PDF)

1 – 25 von 363

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(350)
Mit Volltextzugriff
(323)

Publikationsform

Artikel
(363)

Sprache

Englisch
(360)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(336)
Science & Technology
(326)
Life Sciences & Biomedicine
(318)
Female
(220)
Middle Aged
(193)
Aged
(168)
Biological And Medical Sciences
(152)
Medical Sciences
(142)
Adult
(140)
Oncology
(113)
Risk Factors
(94)
Case-Control Studies
(77)
Animals
(65)
Tumors
(63)
Aged, 80 And Over
(60)
Prospective Studies
(60)
Public, Environmental & Occupational Health
(50)
Insulin-Like Growth Factor Binding Protein 3 - Blood
(49)
Cohort Studies
(47)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation

Metformin reduces endogenous reactive oxygen species and associated DNA damage

The Use of Aspirin and the Risk of Mortality in Patients with Prostate Cancer

Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms

The Use of Metformin and Colorectal Cancer Incidence in Patients with Type II Diabetes Mellitus

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

Prediagnostic plasma IGFBP‐1, IGF‐1 and risk of prostate cancer

Type 2 diabetes and the risk of mortality among patients with prostate cancer

eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes

The use of metformin in patients with prostate cancer and the risk of death

Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms

A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts

A hydride transfer complex reprograms NAD metabolism and bypasses senescence

Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin

Hyperglycemia, Insulin Resistance, Impaired Pancreatic β-Cell Function, and Risk of Pancreatic Cancer

Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

Aktive Filter

Suchergebnisse filtern